Truist lowered the firm’s price target on Nuveen Churchill (NCDL) to $16 from $18 and keeps a Buy rating on the shares as part of a broader research on BDCs – business development companies – with updates on several models post earnings. The modest decline in 2026 estimate results from lower assumed portfolio growth as the firm assumes utilization of its recently announced $50M share repurchase plan this year, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NCDL:
- Nuveen Churchill price target lowered to $13 from $14 at Wells Fargo
- Nuveen Churchill reports Q4 EPS 44c, consensus 43c
- Nuveen Churchill Posts 2025 Results, Launches Buyback Program
- Nuveen Churchill Direct Lending Prices Major Debt Refinancing
- Nuveen Churchill price target lowered to $16 from $18 at Citizens